Injection of monoclonal antibodies can reduce the concentration of new coronaviruses in the nose

In a press release issued the same day, Regenerative Meta revealed that no one developed symptoms of neo-coronary pneumonia after injecting two monoclonal antibody mixtures into 186 people living in the same room as those diagnosed with the new coronavirus.
trials are still ongoing and the results have not yet been published in peer-reviewed journals.
, however, the company said analysis of nasal swab samples from subjects showed significantly lower concentrations of the new coronavirus in the noses of people who had been injected with antibodies than those in the comfort group infected with the new coronavirus.
antibodies have been high hopes in the treatment of new coronary pneumonia.
antibodies prevent the virus from infecting cells by binding to the prickly protein of the new coronavirus.
advantage of monoclonal antibodies is that they work immediately when injected into the body, and it takes weeks after a person is vaccinated to develop a stable immunity.
monoclonal antibodies are also effective in people with low immune function who do not have a strong immune response after vaccination.
Ward, a clinician at King's College London, said: "This approach protects patients receiving chemotherapy for cancer, controls/prevents outbreaks of neo-coronary pneumonia and relieves pressure on health services.
. drugmaker Lilly said on January 21st that its antibody drugs could prevent residents and staff in nursing homes and other long-term care facilities from developing new coronary pneumonia.
people who received a placebo at the same care facility had a 57 percent lower risk of developing neo-coronary pneumonia than those who received their antibody drug bamlanivimab.
the risk of illness could be reduced by up to 80 per cent if only nursing home residents were assessed.
the U.S. Food and Drug Administration has approved the emergency use of monoclonal antibodies from Lilly and Regenerative, which are used as therapeutic drugs in certain populations.
this, science magazine reported that there are several vaccines to fight the new coronavirus, monoclonal antibodies are expensive, how to use antibodies to defeat the new coronavirus there are still many problems.